Open Access

MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells

  • Authors:
    • Fen Huang
    • Bo Wang
    • Jiangzheng Zeng
    • Shenggang Sang
    • Junhua Lei
    • Yanda Lu
  • View Affiliations

  • Published online on: February 5, 2018     https://doi.org/10.3892/ol.2018.7951
  • Pages: 4797-4804
  • Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Programmed cell death‑1 (PD‑1) is an oncogene associated with suppressing proliferation and cytokine production of T cells in the progression of liver cancer. microRNAs (miRs) regulate gene expression via specific binding to the target 3'untranslated region of mRNA. In the present study, miR‑374b was indicated to interact with PD‑1 and affect the tumor‑targeting capacity of cytokine‑induced killer (CIK) cells. miR‑374b inhibitor significantly increased PD‑1 expression in CIK cells. A synthetic small interfering (si)RNA targeting PD‑1 was employed to silence the expression level of PD‑1 in CIK cells. Then, the antitumor effect of siPD‑1 in CIK cells was investigated. In vitro study demonstrated that IFN‑γ secretion and the concentration of lactate dehydrogenase were significantly increased in the PD‑1 knockdown group; however, the viability of HepG2 cells in the PD‑1 knockdown group had significantly decreased, compared with the HepG2 cells in the negative control group. In vivo study indicated that mice inoculated with HepG2 cells and CIK cells with PD‑1 knocked down had a significantly smaller tumor volume, compared with the control group. To conclude, human CIK cells transfected with siPD‑1 can target liver cancer cells and enhance immunotherapy efficacy, and therefore they have potential in the immunotherapy of liver cancer.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Huang F, Wang B, Zeng J, Sang S, Lei J and Lu Y: MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells. Oncol Lett 15: 4797-4804, 2018
APA
Huang, F., Wang, B., Zeng, J., Sang, S., Lei, J., & Lu, Y. (2018). MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells. Oncology Letters, 15, 4797-4804. https://doi.org/10.3892/ol.2018.7951
MLA
Huang, F., Wang, B., Zeng, J., Sang, S., Lei, J., Lu, Y."MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells". Oncology Letters 15.4 (2018): 4797-4804.
Chicago
Huang, F., Wang, B., Zeng, J., Sang, S., Lei, J., Lu, Y."MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells". Oncology Letters 15, no. 4 (2018): 4797-4804. https://doi.org/10.3892/ol.2018.7951